Skip to main content
VCbacked
Log inGet Started

Magnitude Biosciences

Durham, United Kingdom

Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.

$951K raised
May 2025
Seed
BiotechnologyFitnessHealth CarePharmaceutical

Top Investors

Northstar VenturesInnovate UKFinance Durham FundFuture FundNPIF Maven Equity Finance

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Magnitude Biosciences

How much funding has Magnitude Biosciences raised?
Magnitude Biosciences has raised $951K in total funding. The most recent round was Seed. The last funding was announced in May 2025.
Who are Magnitude Biosciences's investors?
Magnitude Biosciences's investors include Northstar Ventures, Innovate UK, Finance Durham Fund, Future Fund, NPIF Maven Equity Finance.
Where is Magnitude Biosciences headquartered?
Magnitude Biosciences is headquartered in Durham, United Kingdom.
What does Magnitude Biosciences do?
Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
What stage is Magnitude Biosciences at?
Magnitude Biosciences is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Magnitude Biosciences — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/magnitude-biosciences. Accessed June 4, 2026.
APA
VCBacked. (2025). Magnitude Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/magnitude-biosciences
Wikipedia (cite web)
{{cite web |title=Magnitude Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/magnitude-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong